ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 32951 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 32951; 2) Community: the network communities that were significantly associated with the response to NSC 32951; 3) Molecule: the relationships between components within communities and NSC 32951; 4) MDR: the compounds that were significantly associated with the NSC 32951.

NSC Compound Enrichment Correlation
NSC 354258 Null 0.0112341530780141 0.36246332
NSC 102627 Yoshi 864 0.0114553853234976 -0.041553111
NSC 139021 1-(2-Thiazolylazo)-2-naphthol 0.0114553853234976 0.30458484
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0114553853234976 0.50453255
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0114553853234976 -0.23284658
NSC 38090 Null 0.0114553853234977 0.73358469
NSC 381866 BAFILOMYCIN DERIV. 0.0114553853234977 0.13498628
NSC 44580 9H-Purin-2-amine, 6-[[(2-chlorophenyl)methyl]thio]-9-propyl- 0.0114553853234977 0.22294038
NSC 59994 Null 0.0114553853234977 0.50567741
NSC 633912 Null 0.0114553853234977 0.33299998
Total:71  Current:16    [First] [Prev] [Next] [Last]